# BOLD (Boundless Bio, Inc.) - SEC EDGAR Financial Statements

> Boundless Bio, Inc. reported $63.59M in total assets and a net loss of $55.50M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/BOLD
- Markdown: https://convexityos.com/fundamentals/BOLD.md
- SEC CIK: 0001782303
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001782303&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$59.06M | Operating profit |
| Net Income | FY 2025 | -$55.50M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.43 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$57.40M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $62.89M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Research & Development | $44.84M | $55.27M | $42.64M |
| Total Operating Expenses | $63.55M | $73.27M | $54.80M |
| **Operating Income** | -$63.55M | -$73.27M | -$54.80M |
| **EBITDA** | -$62.30M | -$72.18M | -$53.84M |
| Interest Income | $5.36M | $7.89M | $5.28M |
| Income Tax Expense | $0 | $0 | -- |
| **Net Income** | -$58.20M | -$65.36M | -$49.43M |
| Basic EPS | -$2.60 | -$3.85 | -$40.65 |
| **Diluted EPS** | -$2.60 | -$3.85 | -$40.65 |
| Basic Shares Outstanding | 22.4M | 17.0M | 1.2M |
| Diluted Shares Outstanding | 22.4M | 17.0M | 1.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.44M | $13.97M | $9.73M | $9.82M | $10.67M | $12.22M | $12.14M | $13.31M |
| Total Operating Expenses | $6.20M | $24.38M | $14.47M | $14.00M | $15.15M | $17.06M | $17.34M | $18.28M |
| **Operating Income** | -$6.20M | -$24.38M | -$14.47M | -$14.00M | -$15.15M | -$17.06M | -$17.34M | -$18.28M |
| **EBITDA** | -$6.10M | -$23.13M | -$14.19M | -$13.70M | -$14.84M | -$16.74M | -$17.02M | -$17.98M |
| Interest Income | $572K | $690K | $920K | $1.12M | $1.27M | $1.39M | $1.58M | $1.92M |
| **Net Income** | -$5.36M | -$23.69M | -$13.55M | -$12.88M | -$13.88M | -$15.68M | -$15.76M | -$16.45M |
| Basic EPS | -$0.23 | -$1.06 | -$0.60 | -- | -$0.62 | -$0.70 | -$0.71 | -- |
| **Diluted EPS** | -$0.23 | -$1.06 | -$0.60 | -- | -$0.62 | -$0.70 | -$0.71 | -- |
| Basic Shares Outstanding | 22.9M | 22.4M | 22.4M | -- | 22.4M | 22.4M | 22.3M | -- |
| Diluted Shares Outstanding | 22.9M | 22.4M | 22.4M | -- | 22.4M | 22.4M | 22.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $17.87M | $26.59M | $23.71M |
| Short-Term Investments | $89.71M | $125.5M | $97.05M |
| **Cash & Short-Term Investments** | $107.6M | $152.1M | $120.8M |
| **Total Current Assets** | $109.6M | $154.4M | $124.2M |
| Property, Plant & Equipment, Net | $3.22M | $4.32M | $2.57M |
| **Total Non-Current Assets** | $47.45M | $52.02M | $5.69M |
| **Total Assets** | $157.1M | $206.4M | $129.9M |
| Accounts Payable | $1.49M | $1.27M | $2.22M |
| **Total Current Liabilities** | $12.54M | $8.13M | $9.36M |
| **Total Non-Current Liabilities** | $45.87M | $47.63M | $0 |
| **Total Liabilities** | $58.41M | $55.77M | $9.36M |
| **Total Debt (incl. Leases)** | $49.03M | $47.63M | $2.19M |
| Common Stock | $2.0K | $2.0K | $0 |
| Retained Earnings | -$259.7M | -$201.5M | -$136.1M |
| Accumulated Other Comp. Income | $64K | $121K | $40K |
| **Total Stockholders' Equity** | $98.65M | $150.6M | -$127.1M |
| Total Equity | $98.65M | $150.6M | -$127.1M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $34.91M | $20.21M | $17.48M | $17.87M | $14.98M | $14.70M | $15.12M | $26.59M |
| Short-Term Investments | $27.98M | $52.41M | $75.36M | $89.71M | $102.6M | $112.5M | $123.1M | $125.5M |
| **Cash & Short-Term Investments** | $62.90M | $72.60M | $92.80M | $107.6M | $117.6M | $127.1M | $138.3M | $152.1M |
| **Total Current Assets** | $63.59M | $73.65M | $94.62M | $109.6M | $120.2M | $129.7M | $140.4M | $154.4M |
| Property, Plant & Equipment, Net | $0 | $97K | $2.94M | $3.22M | $3.50M | $3.79M | $4.08M | $4.32M |
| **Total Non-Current Assets** | $0 | $97K | $46.35M | $47.45M | $48.56M | $49.76M | $50.88M | $52.02M |
| **Total Assets** | $63.59M | $73.74M | $141.0M | $157.1M | $168.7M | $179.5M | $191.2M | $206.4M |
| Accounts Payable | $814K | $1.05M | $2.04M | $1.49M | $1.14M | $2.29M | $1.37M | $1.27M |
| **Total Current Liabilities** | $1.87M | $7.77M | $9.58M | $12.54M | $11.85M | $9.21M | $6.34M | $8.13M |
| **Total Non-Current Liabilities** | $0 | $0 | $45.00M | $45.87M | $46.71M | $47.55M | $48.31M | $47.63M |
| **Total Liabilities** | $1.87M | $7.77M | $54.59M | $58.41M | $58.55M | $56.76M | $54.65M | $55.77M |
| **Total Debt (incl. Leases)** | -- | -- | $48.29M | $49.03M | $49.76M | $49.51M | $48.57M | $47.63M |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Retained Earnings | -$302.3M | -$296.9M | -$273.2M | -$259.7M | -$246.8M | -$232.9M | -$217.2M | -$201.5M |
| Accumulated Other Comp. Income | -$19K | -$32K | -$23K | $64K | $50K | -$4.0K | $32K | $121K |
| **Total Stockholders' Equity** | $61.72M | $65.98M | $86.38M | $98.65M | $110.2M | $122.7M | $136.6M | $150.6M |
| Total Equity | $61.72M | $65.98M | $86.38M | $98.65M | $110.2M | $122.7M | $136.6M | $150.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | -$58.20M | -$65.36M | -$49.43M |
| Depreciation & Amortization | $1.25M | $1.09M | $957K |
| Stock-Based Compensation | $6.12M | $7.52M | $3.34M |
| **Operating Cash Flow** | -$46.66M | -$60.84M | -$46.85M |
| Capital Expenditure | -$546K | -$2.54M | -$633K |
| **Free Cash Flow** | -$47.21M | -$63.38M | -$47.49M |
| Purchases of Investments | -$174.9M | -$208.5M | -$160.1M |
| Sales & Maturities of Investments | $213.2M | $184.9M | $122.5M |
| **Investing Cash Flow** | $37.80M | -$26.10M | -$38.26M |
| **Financing Cash Flow** | $141K | $89.82M | $97.90M |
| **Net Change in Cash** | -$8.72M | $2.88M | $12.78M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.36M | -$23.69M | -$13.55M | -$12.88M | -$13.88M | -$15.68M | -$15.76M | -$16.45M |
| Depreciation & Amortization | $97K | $1.26M | $284K | $307K | $310K | $317K | $317K | $296K |
| Stock-Based Compensation | $284K | $3.22M | $1.37M | $1.33M | $1.30M | $1.69M | $1.80M | $2.01M |
| **Operating Cash Flow** | -$10.88M | -$20.97M | -$14.97M | -$10.11M | -$10.20M | -$11.83M | -$14.53M | -$15.56M |
| Capital Expenditure | $0 | -$38K | -$8.0K | -$424K | -$15K | -$48K | -$59K | -$466K |
| **Free Cash Flow** | -$10.88M | -$21.01M | -$14.98M | -$10.53M | -$10.21M | -$11.88M | -$14.59M | -$16.03M |
| Purchases of Investments | $0 | -$8.39M | -$29.41M | -$39.10M | -$39.51M | -$43.66M | -$52.62M | -$47.44M |
| Sales & Maturities of Investments | $24.50M | $31.50M | $44.00M | $52.50M | $50.00M | $55.00M | $55.74M | $49.73M |
| **Investing Cash Flow** | $24.77M | $23.07M | $14.59M | $12.97M | $10.48M | $11.29M | $3.06M | $1.82M |
| **Financing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $113K |
| **Net Change in Cash** | $14.70M | $2.17M | -$385K | $2.89M | $283K | -$420K | -$11.47M | -$13.63M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Return on Equity (ROE) | -59.0% | -43.4% | -- |
| Return on Assets (ROA) | -37.1% | -31.7% | -38.1% |
| Current Ratio | 8.74x | 18.98x | 13.27x |
| Quick Ratio | 8.58x | 18.70x | 12.90x |
| Debt to Equity | 0.50x | 0.32x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -89.9% | -97.0% | -64.8% | -59.0% | -56.1% | -52.5% | -48.1% | -43.4% |
| Return on Assets (ROA) | -87.3% | -86.8% | -39.7% | -37.1% | -36.6% | -35.9% | -34.3% | -31.7% |
| Current Ratio | 33.97x | 9.48x | 9.87x | 8.74x | 10.14x | 14.08x | 22.15x | 18.98x |
| Quick Ratio | 33.60x | 9.35x | 9.68x | 8.58x | 9.93x | 13.80x | 21.82x | 18.70x |
| Debt to Equity | -- | -- | 0.56x | 0.50x | 0.45x | 0.40x | 0.36x | 0.32x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
